Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
about
Present and future challenges in the treatment of haemophilia: the patient's perspectiveThe demand for polyvalent immunoglobulins in Italy.Public expenditure for plasma-derived and recombinant medicinal products in Italy.Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing.Use of fresh-frozen plasma in 2012 at the Fondazione Ca' Granda Hospital of Milan: assessment of appropriateness using record linkage techniques applied to data routinely recorded in various hospital information systems.Plasma-derived medicinal products: demand and clinical use.
P2860
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
@en
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
@nl
type
label
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
@en
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
@nl
prefLabel
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
@en
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
@nl
P2093
P2860
P356
P1476
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.
@en
P2093
Fabio Candura
Gabriele Calizzani
Giancarlo M Liumbruno
Giuliano Grazzini
Livia Cannata
Liviana Catalano
Monica Lanzoni
Rosa Chianese
Samantha Profili
Stefania Vaglio
P2860
P304
P356
10.2450/2013.018S
P478
11 Suppl 4
P577
2013-09-01T00:00:00Z